NCT02527785 - Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

April 30, 2017

Conditions

Stomach Neoplasm

Interventions

DRUG

Oxaliplatin, Irinotecan, S-1(OIS)

"Treatment will be delivered every 2 weeks~1. oxaliplatin 65 mg/m2 iv on day 1~2. irinotecan 135 mg/m2 iv on day 1~3. S-1 80 mg/m2/day po on day 1-7"

Trial Locations (1)

Hallym university medical center, Anyang